MYCOF - Mydecine Innovations Group GAAP EPS of -$0.35 November, 15 2022 06:23 AM New Age Brands Mydecine Innovations Group press release ( OTCPK:MYCOF ): Q3 GAAP EPS of -$0.35. The company had $0.08M in cash and cash equivalents as of September 30, 2022. For further details see: Mydecine Innovations Group GAAP EPS of -$0.35